Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
 WAIVER

 This WAIVER (this “Waiver”) is made and entered into as of January 18, 2017, by and between Tang Capital
Partners, LP, a Delaware limited partnership (“TCP”), and Heron Therapeutics, Inc., a Delaware corporation formerly known as A.P. Pharma, Inc. (“Heron”), with respect to the Securities Purchase Agreement, dated
April 24, 2011 (the “SPA”), by and among Heron, TCP, Baker Bros. Investments II, L.P., a Delaware limited partnership (“BBI”), Baker Brothers Life Sciences, L.P., a Delaware limited partnership
(“BBLS”), and 14159, L.P., a Delaware limited partnership (together with TCP, BBI and BBLS, the “Purchasers”). 

WHEREAS, pursuant to the SPA, the Purchasers acquired from Heron certain Senior Convertible Notes due 2021 (the “Notes”),
convertible into Heron’s common stock, $0.01 par value per share (the “Common Stock”), subject to certain terms and conditions pursuant to Section 3 of the Notes (the “Conversion Right”); 

WHEREAS, pursuant to Section 6.11 of the SPA, Heron is obligated to have authorized and reserved, for the purpose of issuance upon
conversion of the Notes, no less than the number of shares of Common Stock issuable upon the conversion of the aggregate principal amount and the accrued and unpaid PIK Interest (as such term is defined in the SPA), potentially issuable under the
Notes through the Maturity Date (as such term is defined in the Notes) (such requirement, the “Reservation Requirement”); 

WHEREAS, pursuant to Section 15.1 of the SPA, the holders of the Notes representing at least a majority of the aggregate principal amount
of the Notes then outstanding may waive any provisions under the SPA with the approval of Heron, and TCP holds Notes representing at least a majority of the aggregate principal amount of the Notes now outstanding; and 

WHEREAS, TCP desires to waive the Reservation Requirement and its Conversion Right with respect to the Notes held by TCP (the “TCP
Notes”) as set forth below, subject to the terms and conditions of this Waiver. 
 NOW, THEREFORE, in consideration of the
foregoing premises and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 

1. Waiver. TCP hereby irrevocably waives the Reservation Requirement and Conversion Right, with respect to the TCP Notes only, until the
earliest to occur of: (i) the date that Heron is required to issue a Change of Control Notice (as such term is defined in the Notes); (ii) the date that Heron’s stockholders approve an increase of the number of authorized shares of
Common Stock under Heron’s Certificate of Incorporation; and (iii) July 18, 2017. The date on which TCP’s waiver terminates pursuant to the foregoing provision is referred to herein as the “Termination Date.” For
the avoidance of doubt, the foregoing Waiver does not affect the Reservation Requirement or Conversion Right for any Purchaser other than TCP. 

 2. Repayment Obligation. If at any time following the Termination Date: (i) TCP seeks
to exercise its Conversion Right, in full or in part, with respect to the TCP Notes; and (ii) Heron does not have authorized and reserved at least the number of shares of Common Stock issuable upon the exercise of TCP’s Conversion Right
with respect to the portion of the TCP Notes that TCP desires to convert, Heron shall be obligated to make a cash payment to TCP equal to the value of the shares of Common Stock that Heron is unable to issue to TCP upon the exercise of its
Conversation Right. For the purposes of this Waiver, the value of such shares of Common Stock shall be deemed to equal the closing price of the Common Stock on the Nasdaq Capital Market on the Trading Day (as defined in the Notes) immediately
preceding to the date that TCP submits the Conversion Notice to Heron. 
 3. Governing Law. THIS WAIVER SHALL BE GOVERNED BY INTERNAL
LAWS OF THE STATE OF CALIFORNIA, REGARDLESS OF CHOICE OF LAWS PROVISIONS OF SUCH STATE OR ANY OTHER JURISDICTION. 
 4. Counterparts.
This Waiver may be executed by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

Signature page follows. 

  
 2 

 IN WITNESS WHEREOF, the parties have executed and delivered this Waiver as of the date first
above written. 
  

			
	TANG CAPITAL PARTNERS, LP
		
	By:	 	 /s/ Kevin Tang

	Name:	 	Kevin Tang
	Title:	 	Manager of Tang Capital Management, LLC, General Partner

  

			
	HERON THERAPEUTICS, INC.
		
	By:	 	 /s/ David L. Szekeres

	Name:	 	David L. Szekeres
	Title:	 	Senior Vice President, General Counsel, Business Development & Corporate Secretary

 Signature Page to Waiver 

(Convertible Note)Exhibit

Exhibit 10.1

CONSENT MEMORANDUM

	
		
	TO:
	MTS Systems Corporation Lender Group

	RE:
	Consent re: Extension for Delivery of Annual Financials

	DATE:
	January 17, 2017

	 
	 

Reference is hereby made to the Credit Agreement, dated as of July 5, 2016 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among MTS Systems Corporation, as the Company (the “Company”), the Foreign Subsidiary Borrowers from time to time party thereto, the Lenders from time to time party thereto (collectively, the “Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”).  Terms used herein and not otherwise defined herein shall have the meanings set forth in the Credit Agreement.
The Company has informed the Administrative Agent and the Lenders that it has initiated an internal investigation into apparent violations of the Company’s code of conduct involving certain employees in its China operations.  As a result of such investigation, the Company has informed the Administrative Agent and the Lenders that it (a) will need an extension under the Credit Agreement in order to furnish its financial statements (and related deliveries) for the annual period ended October 1, 2016 (such financial statements and related deliveries, collectively, the “2016 Annual Financials”), as currently required by Sections 5.01(a) and 5.01(c) of the Credit Agreement and (b) has not filed with the SEC its Annual Report on Form 10-K (and related deliveries) for the annual period ended October 1, 2016 (such financial statements and related deliveries, collectively, the “2016 10-K”) on or before the applicable deadline established by the SEC with respect to such periodic report of the Company.  
The Company has additionally informed the Administrative Agent and the Lenders that it may desire to modify the fiscal year of one or more of its Subsidiaries in order to coincide with the fiscal year of the Company.
The Company has therefore requested that the Administrative Agent and the Required Lenders consent to and agree (the “Consent”) that: 
(a) any Default or Event of Default that may have occurred and is continuing or may occur, in each case pursuant to clauses (c), (d) and/or (e) of Article VII of the Credit Agreement, solely and directly as a result of (i) any failure of the Company to provide the 2016 Annual Financials on or before the deadline set forth in Section 5.01(a) or 5.01(c) of the Credit Agreement, (ii) any failure of the Company to provide its financial statements (and related deliveries) for the quarterly period ended December 31, 2016 (such financial statements and related deliveries, collectively, the “2017 Q1 Financials”) on or before the deadline set forth in Section 5.01(b) or 5.01(c) of the Credit Agreement, (iii) any failure of the Company to file with the SEC the 2016 10-K on or before the applicable deadline established by the SEC with respect to such periodic report of the Company, (iv) any failure of the Company to file with the SEC its Quarterly Report on Form 10-Q (and related deliveries) for the quarterly period ended December 31, 2016 on or before the applicable deadline established by the SEC with respect to such periodic report of the Company and/or (v) any failure of the Company to provide any notice of the foregoing, are each hereby waived; provided that, the Company shall furnish to the 

Administrative Agent and the Lenders the 2016 Annual Financials and the 2017 Q1 Financials by no later than April 24, 2017; and
(b) Section 6.03(c) of the Credit Agreement is hereby amended to add the following proviso at the end thereof (and to make any related punctuation changes as a result thereof): “; provided that, the fiscal year of any Subsidiary may be changed to be the same as the fiscal year of the Company in effect on the Effective Date.”;
provided that, it is hereby understood and agreed that if the Company fails to provide the Administrative Agent and the Lenders with the 2016 Annual Financials and the 2017 Q1 Financials by April 24, 2017, clause (a) of this Consent shall cease to be effective, the Administrative Agent and the Lenders shall have all the rights and remedies afforded by the Credit Agreement and the other Loan Documents as if such Consent had never been granted, and an immediate Event of Default shall be deemed to have occurred under the Credit Agreement.

Please indicate your Consent, as soon as possible but in no event later than 5:00 p.m. (New York City time) on January 23, 2017, by executing a counterpart of your attached signature page to this Consent Memorandum and, upon execution, returning a copy by fax or e-mail to the attention of Zeynep Gieseke at Latham & Watkins LLP, counsel to the Administrative Agent (fax number: 312.993.9767; e-mail:  Zeynep.Gieseke@lw.com).  Please make any necessary corrections or adjustments to your signature block prior to execution and delivery.  This Consent Memorandum will be effective upon the Administrative Agent’s receipt of (i) executed signature pages via facsimile or e-mail from the Company, the Administrative Agent and the Required Lenders pursuant to Section 9.02 of the Credit Agreement and (ii) all fees (including consent fees payable to the Lenders) and any other amounts due and payable in connection with this Consent Memorandum, including reasonable and documented out-of-pocket fees and expenses of counsel for the Administrative Agent. 
Each reference in the Credit Agreement to “this Credit Agreement,” “this Agreement,” “hereunder,” “hereof,” “herein,” and words of like import, and each reference in the other Loan Documents to the Credit Agreement (including, without limitation, by means of words like “thereunder”, “thereof”, “therein” and words of like import), shall mean and be a reference to the Credit Agreement after giving effect to this Consent Memorandum; and this Consent Memorandum and the Credit Agreement shall be read together and construed as a single instrument.  This Consent Memorandum is a Loan Document.  Except as expressly set forth herein, (i) all of the terms and provisions of the Credit Agreement and all other Loan Documents are and shall remain in full force and effect and are hereby ratified and confirmed and (ii) the execution, delivery and effectiveness of this Consent Memorandum shall not operate as a waiver of any right, power or remedy of the Lenders or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of any of the Loan Documents.
All of the terms and provisions of this Consent Memorandum shall bind and inure to the benefit of the parties hereto and their respective successors and assigns.
This Consent Memorandum may be executed by one or more of the parties hereto on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.  Delivery of an executed counterpart of a signature page to this Consent Memorandum by facsimile or other electronic imaging shall be effective as delivery of a manually executed counterpart of this Consent Memorandum.  This Consent Memorandum shall be governed by and construed in accordance with the laws of the State of New York.

[Signature Pages Follow]

2

	
		
	JPMORGAN CHASE BANK, N.A.,

	as Administrative Agent

	 
	 

	 
	 

	By:
	 

	Name:

	Title:

Signature Page to Consent Memorandum
MTS Systems Corporation

	
		
	Name of Lender:

	 

	 

	 
	 

	 
	 

	 
	 

	By
	 

	 
	Name:

	 
	Title:

	 
	 

	 
	 

	 
	 

	For any Lender requiring a second signature line:

	 
	 

	 
	 

	By
	 

	 
	Name:

	 
	Title:

Signature Page to Consent Memorandum
MTS Systems Corporation

	
		
	Acknowledged and Agreed:

	 
	 

	 
	 

	MTS SYSTEMS CORPORATION

	 
	 

	 
	 

	By:
	 

	Name:

	Title:

Signature Page to Consent Memorandum
MTS Systems Corporation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]